Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Protein Kinase Inhibitors | 13 | 2024 | 5522 | 0.520 |
Why?
|
Cyclin-Dependent Kinases | 3 | 2022 | 670 | 0.460 |
Why?
|
Drug Discovery | 5 | 2021 | 1057 | 0.350 |
Why?
|
Protein Kinases | 3 | 2024 | 1638 | 0.310 |
Why?
|
Proto-Oncogene Proteins c-met | 2 | 2020 | 578 | 0.270 |
Why?
|
Pyrimidines | 7 | 2024 | 2933 | 0.250 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 2 | 2024 | 187 | 0.240 |
Why?
|
src-Family Kinases | 3 | 2020 | 551 | 0.230 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2022 | 1860 | 0.230 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 1 | 2023 | 33 | 0.230 |
Why?
|
Drug Design | 5 | 2021 | 1078 | 0.220 |
Why?
|
MAP Kinase Kinase 4 | 2 | 2020 | 148 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-hck | 1 | 2021 | 46 | 0.210 |
Why?
|
Chromatography, Affinity | 1 | 2023 | 549 | 0.210 |
Why?
|
Molecular Probes | 1 | 2023 | 316 | 0.200 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2023 | 452 | 0.190 |
Why?
|
MAP Kinase Kinase 7 | 1 | 2020 | 14 | 0.190 |
Why?
|
Creatine | 1 | 2023 | 421 | 0.190 |
Why?
|
Creatine Kinase | 1 | 2023 | 694 | 0.190 |
Why?
|
Peptide Termination Factors | 1 | 2020 | 55 | 0.190 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2021 | 250 | 0.180 |
Why?
|
NF-E2-Related Factor 2 | 1 | 2022 | 364 | 0.180 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 3 | 2023 | 182 | 0.170 |
Why?
|
CDC2 Protein Kinase | 1 | 2020 | 220 | 0.170 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 2 | 2009 | 91 | 0.170 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2022 | 559 | 0.170 |
Why?
|
TRPM Cation Channels | 1 | 2020 | 140 | 0.170 |
Why?
|
Cysteine | 2 | 2023 | 873 | 0.170 |
Why?
|
Geologic Sediments | 1 | 2019 | 76 | 0.170 |
Why?
|
Bacillus | 1 | 2019 | 77 | 0.170 |
Why?
|
Seawater | 1 | 2019 | 121 | 0.160 |
Why?
|
Bile Duct Neoplasms | 1 | 2024 | 567 | 0.160 |
Why?
|
Cholangiocarcinoma | 1 | 2024 | 516 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2023 | 1158 | 0.160 |
Why?
|
Lactic Acid | 1 | 2023 | 1132 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2021 | 571 | 0.150 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 3123 | 0.150 |
Why?
|
Anilides | 1 | 2020 | 404 | 0.140 |
Why?
|
Lymphoma, B-Cell | 1 | 2023 | 930 | 0.140 |
Why?
|
Small Molecule Libraries | 2 | 2020 | 721 | 0.140 |
Why?
|
Adenine | 1 | 2021 | 936 | 0.140 |
Why?
|
Kidney Neoplasms | 3 | 2020 | 4229 | 0.130 |
Why?
|
Thalidomide | 1 | 2020 | 888 | 0.130 |
Why?
|
Neoplasms | 5 | 2023 | 21596 | 0.130 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2020 | 713 | 0.130 |
Why?
|
Cell Cycle | 1 | 2023 | 2964 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2431 | 0.120 |
Why?
|
Benzimidazoles | 2 | 2009 | 848 | 0.120 |
Why?
|
Cell Line, Tumor | 9 | 2021 | 16665 | 0.120 |
Why?
|
Phylogeny | 2 | 2019 | 2797 | 0.110 |
Why?
|
Piperidines | 1 | 2021 | 1602 | 0.110 |
Why?
|
Cell Cycle Proteins | 2 | 2023 | 3444 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2022 | 2938 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2023 | 5163 | 0.110 |
Why?
|
Structure-Activity Relationship | 5 | 2022 | 3133 | 0.110 |
Why?
|
Lymphoma | 1 | 2021 | 1873 | 0.110 |
Why?
|
Anthracenes | 1 | 2011 | 84 | 0.100 |
Why?
|
Fusion Proteins, bcr-abl | 2 | 2010 | 433 | 0.100 |
Why?
|
Cell Proliferation | 7 | 2023 | 10472 | 0.100 |
Why?
|
Peptides | 1 | 2023 | 4392 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1790 | 0.090 |
Why?
|
Apoptosis | 3 | 2023 | 9715 | 0.090 |
Why?
|
Dietary Fiber | 1 | 2014 | 760 | 0.090 |
Why?
|
Neutrophils | 1 | 2022 | 3711 | 0.090 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2915 | 0.090 |
Why?
|
Plasmodium | 1 | 2011 | 248 | 0.080 |
Why?
|
Antineoplastic Agents | 4 | 2023 | 13655 | 0.080 |
Why?
|
Biocatalysis | 1 | 2009 | 167 | 0.080 |
Why?
|
Static Electricity | 1 | 2009 | 267 | 0.080 |
Why?
|
Molecular Structure | 4 | 2020 | 1907 | 0.080 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 3800 | 0.080 |
Why?
|
Pyrazines | 1 | 2013 | 1231 | 0.080 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2008 | 282 | 0.080 |
Why?
|
Phosphorylation | 4 | 2023 | 8436 | 0.070 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2014 | 798 | 0.070 |
Why?
|
Transcription Factors | 4 | 2023 | 12164 | 0.070 |
Why?
|
Adenosine Triphosphate | 2 | 2024 | 2024 | 0.070 |
Why?
|
Mutation | 6 | 2024 | 29717 | 0.070 |
Why?
|
Models, Molecular | 4 | 2020 | 5454 | 0.070 |
Why?
|
DNA-Binding Proteins | 1 | 2023 | 9639 | 0.070 |
Why?
|
Imidazoles | 1 | 2011 | 1205 | 0.060 |
Why?
|
Conserved Sequence | 1 | 2009 | 1202 | 0.060 |
Why?
|
Antimalarials | 1 | 2011 | 903 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6096 | 0.060 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5851 | 0.060 |
Why?
|
Proteomics | 3 | 2023 | 3618 | 0.060 |
Why?
|
Reperfusion Injury | 1 | 2011 | 1025 | 0.060 |
Why?
|
Piperazines | 2 | 2011 | 2488 | 0.060 |
Why?
|
Signal Transduction | 6 | 2024 | 23387 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 1 | 2023 | 77 | 0.060 |
Why?
|
Anaphase | 1 | 2023 | 120 | 0.060 |
Why?
|
SOXC Transcription Factors | 1 | 2022 | 40 | 0.050 |
Why?
|
Animals | 13 | 2023 | 168561 | 0.050 |
Why?
|
Lipoylation | 1 | 2022 | 64 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2024 | 295 | 0.050 |
Why?
|
Ischemia | 1 | 2011 | 1911 | 0.050 |
Why?
|
Phosphotransferases | 1 | 2023 | 309 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 2 | 1 | 2022 | 191 | 0.050 |
Why?
|
Pyridines | 1 | 2013 | 2818 | 0.050 |
Why?
|
Malaria | 1 | 2011 | 1232 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2014 | 2229 | 0.050 |
Why?
|
Endoribonucleases | 1 | 2023 | 228 | 0.050 |
Why?
|
Humans | 24 | 2024 | 742088 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2020 | 5171 | 0.050 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13019 | 0.050 |
Why?
|
Drug Resistance | 2 | 2021 | 1608 | 0.050 |
Why?
|
Poly A | 1 | 2021 | 185 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 49 | 0.050 |
Why?
|
Ubiquitins | 1 | 2022 | 383 | 0.050 |
Why?
|
Hydrogen Bonding | 1 | 2020 | 293 | 0.050 |
Why?
|
Diaminopimelic Acid | 1 | 2019 | 6 | 0.040 |
Why?
|
Vitamin K 2 | 1 | 2019 | 46 | 0.040 |
Why?
|
Mice | 8 | 2023 | 81045 | 0.040 |
Why?
|
Base Composition | 1 | 2019 | 293 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2020 | 742 | 0.040 |
Why?
|
Databases, Protein | 1 | 2020 | 383 | 0.040 |
Why?
|
Bacterial Typing Techniques | 1 | 2019 | 256 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8425 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1727 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2020 | 936 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2023 | 1284 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1208 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 1 | 2019 | 1374 | 0.040 |
Why?
|
Mammals | 1 | 2023 | 1135 | 0.040 |
Why?
|
Mice, Inbred BALB C | 2 | 2020 | 6382 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2020 | 731 | 0.040 |
Why?
|
Peptidoglycan | 1 | 2019 | 246 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1875 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2013 | 7873 | 0.040 |
Why?
|
Mice, SCID | 1 | 2021 | 2715 | 0.030 |
Why?
|
Blotting, Western | 2 | 2014 | 5180 | 0.030 |
Why?
|
Cell Wall | 1 | 2019 | 422 | 0.030 |
Why?
|
Liver | 1 | 2011 | 7470 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 947 | 0.030 |
Why?
|
Phospholipids | 1 | 2019 | 781 | 0.030 |
Why?
|
Kidney | 1 | 2011 | 7167 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1659 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3293 | 0.030 |
Why?
|
Cell Movement | 2 | 2020 | 5212 | 0.030 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2023 | 1581 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2020 | 1333 | 0.030 |
Why?
|
Fabaceae | 1 | 2014 | 103 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1465 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2022 | 2502 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2021 | 6313 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2014 | 6534 | 0.030 |
Why?
|
Radioligand Assay | 1 | 2013 | 379 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3689 | 0.030 |
Why?
|
Amino Acid Sequence | 2 | 2020 | 13814 | 0.030 |
Why?
|
China | 1 | 2019 | 2246 | 0.030 |
Why?
|
Hematopoiesis | 1 | 2022 | 2066 | 0.030 |
Why?
|
Protein Conformation | 1 | 2020 | 4013 | 0.030 |
Why?
|
Plasmodium yoelii | 1 | 2011 | 39 | 0.030 |
Why?
|
Acyltransferases | 1 | 2013 | 294 | 0.030 |
Why?
|
Cell Line | 2 | 2020 | 15994 | 0.030 |
Why?
|
Sporozoites | 1 | 2011 | 82 | 0.030 |
Why?
|
DNA Damage | 1 | 2021 | 2423 | 0.020 |
Why?
|
Fatty Acids | 1 | 2019 | 1806 | 0.020 |
Why?
|
Plasmodium berghei | 1 | 2011 | 168 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3691 | 0.020 |
Why?
|
Rats, Inbred F344 | 1 | 2011 | 862 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12344 | 0.020 |
Why?
|
Mutagenesis | 1 | 2013 | 1263 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2010 | 408 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2010 | 898 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2013 | 739 | 0.020 |
Why?
|
Fruit | 1 | 2014 | 1139 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2009 | 625 | 0.020 |
Why?
|
Vegetables | 1 | 2014 | 1179 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2723 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9387 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2013 | 4322 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2014 | 3510 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4801 | 0.020 |
Why?
|
Inhibitory Concentration 50 | 1 | 2008 | 459 | 0.020 |
Why?
|
Regional Blood Flow | 1 | 2011 | 1525 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2020 | 3585 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2008 | 563 | 0.020 |
Why?
|
Protein Stability | 1 | 2009 | 556 | 0.020 |
Why?
|
Random Allocation | 1 | 2011 | 2425 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 1083 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29010 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 2009 | 2130 | 0.020 |
Why?
|
Drug Synergism | 1 | 2010 | 1791 | 0.020 |
Why?
|
Models, Chemical | 1 | 2008 | 626 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3612 | 0.020 |
Why?
|
Transfection | 1 | 2014 | 5892 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2011 | 1372 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 4751 | 0.020 |
Why?
|
Rats | 2 | 2013 | 24265 | 0.020 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2009 | 547 | 0.020 |
Why?
|
Protozoan Proteins | 1 | 2011 | 827 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2009 | 1245 | 0.020 |
Why?
|
RNA Interference | 1 | 2014 | 2890 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 13029 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1866 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4211 | 0.020 |
Why?
|
Models, Animal | 1 | 2011 | 2170 | 0.020 |
Why?
|
Middle Aged | 4 | 2020 | 213127 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2077 | 0.010 |
Why?
|
Thiazoles | 1 | 2010 | 1484 | 0.010 |
Why?
|
Benzamides | 1 | 2009 | 1378 | 0.010 |
Why?
|
Female | 5 | 2021 | 379592 | 0.010 |
Why?
|
Enzyme Activation | 1 | 2009 | 3701 | 0.010 |
Why?
|
Erythrocytes | 1 | 2011 | 2452 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.010 |
Why?
|
Male | 5 | 2020 | 349538 | 0.010 |
Why?
|
Plasmodium falciparum | 1 | 2011 | 1726 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21821 | 0.010 |
Why?
|
Binding Sites | 1 | 2010 | 6115 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3847 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12242 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11363 | 0.010 |
Why?
|
Adult | 3 | 2020 | 213712 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11001 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2008 | 2455 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 21719 | 0.010 |
Why?
|
Cytokines | 1 | 2011 | 7317 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2009 | 18112 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2009 | 4664 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56350 | 0.010 |
Why?
|
Time Factors | 1 | 2014 | 40054 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15494 | 0.010 |
Why?
|
Aged | 2 | 2014 | 162944 | 0.010 |
Why?
|
Risk Factors | 1 | 2014 | 72145 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2011 | 62966 | 0.000 |
Why?
|